BACKGROUND: Thinking from ovarian cancer stem cell theory shows that: in the tumor cells, there are a fraction of stem cells with self-renewing ability and multipotent differentiation, which are the root causes of ovarian cancer recurrence and drug resistance. Studies have shown that CD90 can be used as a surface marker of mesenchymal stem cells and stem cells of other cancers.
OBJECTIVE: To explore the biological features of CD90+ tumor cells from ovarian cancer tissues.
METHODS: Primary ovarian cancer cells were isolated from the abdominal dropsy of ovarian cancer patients to sort CD90+ and CD90- cells using flow cytometry. RT-PCR was used to detect expressions of stem cell-related genes and epithelial to mesenchymal transition-related genes. Cell invasion was observed by Transwell invasion assay, cell proliferation and differentiation observed by clone formation assay, stem cell potential observed by suspension sphere-forming assay, and tumor formation rate observed by in vivo tumorigenicity experiment.
RESULTS AND CONCLUSION: Compared with the CD90
- cells, the expressions of CD44, CD133, ALDH1, N-cad and Vimentine were significantly higher in the CD90
+ cells (
P < 0.05), but the expression of E-cad was significantly decreased in the CD90
+ cells (
P < 0.05). Tumor formation rates of CD90
- and CD90
+ cells were increased significantly with the increase of seeded cell number, which was more obvious in CD90
+ cells. The number of transmembrane cells, the number of cell clones and the number of suspended spheres were significantly higher in the CD90
+ cells than the CD90
- cells (
P < 0.05). Experimental findings from this study show that CD90
+ cells highly express epithelial to mesenchymal transition-related genes and stem cell-related genes, with higher invasion, proliferation and differentiation,
in vivo tumorigenicity and potential of stem cells. CD90
+ cell separation may be a new method to separate ovarian cancer stem cells.